6 assets in Pulmonary Hypertension

Therapeutic assets addressing Pulmonary Hypertension, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Uniprost Pulmonary Hypertension	University of California, San Diego	P3	B (62)
Semaglutide Pulmonary Hypertension	University of Pennsylvania	P1/2	CCC (48)
XENON Pulmonary Hypertension	Thunder Bay Regional Health Research Institute	P1	CCC (48)
c106 Pulmonary Hypertension	Vicore Pharma AB	P1	CC (46)
hs135 Pulmonary Hypertension	35Pharma Inc	P1	CC (43)
hs235 Pulmonary Hypertension	35Pharma Inc	P1	CC (43)